A 45-year-old woman with HIV infection presented with thrombotic microangiopathy 1 week after initiating therapy with the nucleoside analogue abacavir. She was successfully treated with plasmapheresis and corticosteroids.
Get full access to this article
View all access options for this article.
References
1.
1. Morris A, Creasman J, Turner J, Luce JM, Wachter RM, Huang L. Intensive care of human immunodeficiency virus-infected patients during the era of highly active antiretroviral therapy . Am J Respir Crit Care Med.2002;166: 262-267 .
2.
2. Sundar K, Suarez M, Banogon PE, Shapiro JM. Zidovudine-induced fatal lactic acidosis and hepatic failure in patients with acquired immunodeficiency syndrome: report of two patients and review of the literature . Crit Care Med.1997;25: 1425-1430 .
3.
3. Staszewski S, Keiser P, Montaner J, et al. Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults: a randomized equivalence trial . JAMA.2001;285: 1155-1163 .
4.
4. Hervey PS, Perry CM. Abacavir: a review of its clinical potential in patients with HIV infection . Drugs.2000;60: 447-479 .
5.
5. Walensky RP, Goldberg JH, Daily JP. Anaphylaxis after rechallenge with abacavir . AIDS.1999;13: 999-1000 .
6.
6. Elliott MA, Nichols WL. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome . Mayo Clin Proc.2001;76: 1154-1162 .
7.
7. Hymes KB, Karpatkin S. Human immunodeficiency virus infection and thrombotic microangiopathy . Semin Hematol.1997;34: 117-125 .
8.
8. Blackall DP, Uhl L, Spitalnik SL, Transfusion Practices Committee. Cryoprecipitate-reduced plasma: rationale for use and efficacy in the treatment of thrombotic thrombocytopenic purpura . Transfusion.2001;41: 840-844 .
9.
9. Godeau B, Caulier MT, Decuypere L, Rose C, Schaeffer A, Bierling P. Intravenous immunoglobulin for adults with autoimmune thrombocytopenic purpura: results of a randomized trial comparing 0.5 and 1 g/kg b.w . Br J Haematol.1999;107: 716-719 .
10.
10. Laurence J, Mitra D, Steiner M, Staianco-Coico L, Jaffe E. Plasma from patients with idiopathic and human immunodeficiency virus-associated thrombotic thrombocytopenic purpura induces apoptosis in microvascular endothelial cells . Blood.1996;87: 3245-3254 .
11.
11. Moake JL, McPherson PD. Abnormalities of von Willebrand factor multimers in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome . Am J Med.1989;87: 9N-15N .
12.
12. Furlan M, Robles R, Solenthaler M, Wassmer M, Sandoz P, Lammle B. Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura . Blood.1997;89: 3097-3103 .
14. Tsai H-M. Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura . J Mol Med.2002;80: 639-647 .
15.
15. Rock G, Porta C, Bobbio-Pallavicini E. Thrombotic thrombocytopenic purpura treatment in year 2000 . Haematologica.2000;85: 410-419 .
16.
16. Rock G, Shumak KH, Sutton DM, Buskard NA, Nair RC. Cryosupernatant as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura. Members of the Canadian Apheresis Group . Br J Haematol.1996;94: 383-386 .
17.
17. de la Rubia J, Lopez A, Arriaga F, et al. Response to plasma exchange and steroids as combined therapy for patients with thrombotic thrombocytopenic purpura . Acta Haematologica.1999;102: 12-16 .
18.
18. Ferrara F, Annunziata M, Pollio F, et al. Vincristine as treatment for recurrent episodes of thrombotic thrombocytopenic purpura . Ann Hematol.2002;81: 7-10 .
19.
19. Badesha PS, Saklayen MG. Hemolytic uremic syndrome as a presenting form of HIV infection . Nephron.1996;72: 472-475 .
20.
20. Cruccu V, Parisio E, Pedretti D, Villa A, Confalonieri F. HIV-related thrombotic thrombocytopenic purpura (TTP) as first clinical manifestation of infection . Haematologica.1994;79: 277-279 .
21.
21. Bachmeyer C, Blanche P, Sereni D, et al. Thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome in HIV-infected patients . AIDS.1995;9: 532-533 .
22.
22. Abraham B, Baud O, Bonnet E, et al. Thrombotic microangiopathy during HIV infection. A retrospective study performed in infectious diseases units in southern France . Presse Medicale.2001;30: 581-585 .
23.
23. del Arco A, Martinez MA, Pena JM, et al. Thrombotic thrombocytopenic purpura associated with human immunodeficiency virus infection: demonstration of p24 antigen in endothelial cells . Clin Infect Dis.1993;17: 360-363 .
24.
24. Gadallah MF, el-Shahawy MA, Campese VM, Todd JR, King JW. Disparate prognosis of thrombotic microangiopathy in HIV-infected patients with and without AIDS . Am J Nephrol.1996;16: 446-450 .
25.
25. Salem G, Terebelo H, Raman S. Human immunodeficiency virus associated with thrombotic thrombocytopenic purpura: successful treatment with zidovudine . South Med J.1991;84: 493-495 .
26.
26. Gordon LI, Kwaan HC. Cancer-and drug-associated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome . Semin Hematol.1997;34: 140-147 .
27.
27. Tsai HM, Rice L, Sarode R, Chow TW, Moake JL. Antibody inhibitors to von Willebrand factor metalloproteinase and increased binding of von Willebrand factor to platelets in ticlopidine-associated thrombotic thrombocytopenic purpura . Ann Intern Med.2000;132: 794-799 .
28.
28. Kojouri K, Vesely SK, George JN. Quinine-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: frequency, clinical features, and long-term outcomes . Ann Intern Med.2001;135: 1047-1051 .
31. Dargere S, Verdon R, Bouher K, Bazin C. Disseminated intravascular coagulation as a manifestation of abacavir hypersensitivity reaction (correspondence) . AIDS.2002;16: 1696-1697 .
32.
32. Escaut L, Liotier JY, Albengres E, Cheminot N, Vittecoq D. Abacavir rechallenge has to be avoided in case of hypersensitivity reaction . AIDS.1999;13: 1419-1420 .
33.
33. Loeliger AE, Steel H, McGuirk S, Powell WS, Hetherington SV. The abacavir hypersensitivity reaction and interruptions in therapy . AIDS.2001;15: 1325 .
